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The specificity ofT lymphocytes derives from the propertiesofclonally distributed
membrane receptors. For most peripheral T cells (CD4+ CD8- and CD4- CD8+),
antigen is corecognized with molecules of the MHC by a receptor consisting ofclonally
diverse aR heterodimers associated with the multichain CD3 complex (1-3). Recently,
a subpopulation ofT cells was described, usually lacking expression of the CD4 and
CD8 cell surface molecules, that uses as its receptor a distinct heterodimer (y8) as-
sociated with CD3 (4-7) . The specificity ofthis new TCR is not well characterized,
although one report of reactivity with a polymorphic MHC-linked molecule has
appeared (8).
The genes encoding each ofthe chains ofthe two receptor heterodimers have been
cloned and analyzed (9-15). Each chain is encoded by a set of gene segments that
undergoes rearrangement during differentiation of the T cell, although the number
of such segments, their diversity in the germline, and the pattern of rearrangement
varies for each locus. Ontogenetic studies have revealed that y and S are rearranged
before R and a (14, 16-20), and T cells expressing y8-CD3 complexes on their cell
surfaces appear in the murine thymus several days before a(3-CD3-expressing cells
(21, 22).
Investigation of TCR gene expression in various cloned cell lines has shown that
most a(3-expressing cells lack an in-frame y gene rearrangement (23) and that most
y8-expressing cells lack mRNA capable of encoding functional a or Q chains (4, 7) .
In addition, the S locus is contained within the a locus, such that VaJa rearrange-
ment will delete the S locus on that chromosome (14). These findings, together with
biochemical studies showing mutually exclusive expression of one or the other of
the types of TCR (aO or yS) on individual T cell clones and the ontogenetic pattern
of receptor expression noted above (21), have led to the hypothesis that yS- and a(3-
expressing T cells represent distinct lineages derived from a common precursor. Suc-
cessful expression of a yS receptor is thought to preclude further receptor gene rear-
rangement, and hence, as expression. A failure to successfully rearrange either y
or S permits continued rearrangement and the eventual expression of an a(3 receptor.
The Journal of Experimental Medicine - Volume 168
￿
September 1988
￿
1003-1020
￿
10031004
￿
CONTROL OF T CELL RECEPTOR DIMER EXPRESSION
This model explains the rare occurrence of in-frame y transcripts in a(3' T cells and
the absence of functional a or R transcripts in yS' cells.
Although the absence of in-frame y rearrangements in most a(3 T cells makes it
unlikely that many yS' cells differentiate further into a(3' cells, it is very difficult
from in vivo studies to rule out the existence of a small population ofT cells in tran-
sition from expression of one type of receptor to another. Furthermore, some ma-
ture T cells have been found to contain at least three potentially functional receptor
chains (11, 24). Because all these chains are expected to share the general structural
features of prototypic Ig domains, it is of interest to know whether pairing and ex-
pression of chains typically associated with distinct TCR dimers could occur and
give rise to unusual types of receptors, perhaps with unique specificities. In the present
report, we analyze these issues by intentionally introducing functional a and/or (3
genes into yS' cells and analyzing the resultant cell surface expression of CD3-
associated heterodimers. Our results demonstrate the potential for simultaneous ex-
pression of both receptor types by a single cell and also reveal a clear absence of
dimers containing mixtures of chains other than the typical a(3 or 'Y8 combinations.
In one case, creation of a functional ao dimer led to the loss of yS expression on
the membrane, consistent with an induced switch from one receptor type to an-
other. However, further study indicated that this change most likely reflected intra-
cellular competition for CD3 components, rather than a genetic event. Overall, the
data support the view that cells express the two types of receptor dimers in a mutu-
ally exclusive manner and that mixtures of receptor chains other than of the ap or
yS types do not occur to a significant extent nor contribute to receptor diversity.
Materials and Methods
Cell Lines andAntibodies.
￿
The human T cell tumor line Jurkat (clone E6.1), expressing
clonotypic TCR (Ti)' a(3 heterodimers (25), and the tumor line PEER, expressing yS het-
erodimers (6), have been described. 2114 is a cytochrome c-specific, I-Ek-restricted murine
T hybridoma, and its characteristics have been described in detail (26). DN7.1 is a YS-
expressing murine hybridoma produced by cell fusion between C57BL/6 dull Ly1' double-
negative thymocytes and Tip- -BW5147, as described (27) .
mAbs used in this study were as follows: A2114.2, a mouse anti-clonotypic antibody recog-
nizing the Tia chain of 2B4 (2, 28); 2C11, a hamster anti-murine CD3 chain antibody (29);
OKT3 (30) and anti-Leu-4 (Becton Dickinson & Co., Sunnyvale, CA), mouse anti-human
CD3 antibodies; WT31, a mouse anti-human Tiao heterodimer antibody (31); OF1, a mouse
anti-human Tip chain framework antibody (32); antiTCRS1, a mouse anti-human Ti8 chain
framework antibody (33); and anti-Cyml, a mouse anti-human y chain constant region an-
tibody (Hochstenbach and Brenner, submitted for publication). Myeloma protein P3 was
used as a control antibody. An antiserum directed against a COOH-terminal peptide of mu-
rine y chains and described previously in detail (7) was kindly provided by J . Coligan (Na-
tional Institute of Allergy and Infectious Diseases, National Institutes of Health). The anti-y
antibody used was purified by affinity chromatography on an appropriate peptide-bearing
column.
Transfection.
￿
The constructs of expressible forms of the 2B4a and R chain genes were de-
scribed previously (2). Briefly, for the a chain, a cDNA clone corresponding to the 2B4a
chain was cloned into a vector containing the Friend spleen focus-forming virus LTR and
neo` gene (p2B4aFneo). For the {3 chain, a rearranged genomic clone was subcloned in
' Abbreviations used in this paper CHAPS, 3-[(3-Cholamidopropyl)dimethyl-ammonio]-propanesul-
fonate; Ti, clonotypic TCR.SAITO ET AL.
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pSV2gpt (p2B40SV2gpt), providing a distinct selective marker usuable in conjunction with
the a gene construct. All transfections were performed by spheroplast fusion (2, 34). Trans-
fected cells were cultured at 105 cells per well in 96-well microtiter plates, and were selected
48 h laterin DMEM containing 10% FCS and appropriate concentrations of selective drugs.
For 2B4a transfection, 1 and 2 mg/ml ofG418 were used for PEER and DN7.1, respectively,
and for 2B4ß transfection, DN7.1 transfectants were selected in the presence of 1 pg/ml
mycophenolic acid, 250 ug/ml xanthine, and 15 wg/ml hypoxanthine. To obtain 2B4a- and
0-transfected DN7.1, one 2B4ß-transfected DN7 .1 clone (DN1-0-1.35) was super-transfected
with p2B4aFneo. Growing colonies were visualized 2-4 wk after transfection and were ex-
panded and maintained in selective medium. Positive clones were screened by both surface
staining with A2B4 and RNA dot blot analysis using Va2B4 or V02B4 probes.
Flow Microfluorimetry.
￿
Cell surface phenotype was determined by flow cytometry on a FAGS
analyzer (Becton Dickinson & Co.). 5 x 105 cells were stained with culture supernatants of
A2B4, OKT3, or 2011, or a 1 :500 dilution of ascites of WT31, followed by fluoresceinated
F(ab')2 goat anti-mouse Ig (Cappel Laboratories, Cochranville, PA), as described (2).
Northern Blot Analysis.
￿
Cytoplasmic RNA was prepared (35) from E6.1, PEER, PE-a-1.3,
2B4, DN7 .1, and 2B4a- and/or 0-transfected DN71 10 pg of total RNA from each cell line
was subjected to electrophoresis on a 1% agarose gel containing 0.22 M formaldehyde for
600 V-h, transferred to nitrocellulose (36), and hybridized to various cDNA probes labeled
by the hexamer-priming method (37). The hybridized blots were washed with 0.1 x SSC
and 0.1% SDS at 60°C . The probes used were a 1.4-kb Eco RI fragment corresponding to
the V, J, and C regions of the human a chain clone PyL4 (13); a 750-bp Bgl II-Apa I frag-
ment corresponding to the human C0 region from pTOFneo (38); a 1.6-kb Eco RI fragment
corresponding to the V, J, and Cyl region ofhuman y chains (kindly provided by Dr. T. W.
Mak); a 1.5-kb Eco RI fragment corresponding to human CS (15); a 340-bp PstI-Pvu II frag-
ment corresponding to the V region of the 2B4a chain (Val1 .2, 39) from pGEM-2B4a (2);
a 310-bp Eco RI-Sca I fragment corresponding to the V region of the 2B4ß chain (12 ; now
called Vß3, [40]) from p2B40SV2gpt (2); and a 600-bp Eco RI fragment corresponding to
the murine Cy2 region (M. Avigan and R. N. Germain, unpublished results).
Cell Labeling and Immunoprecipitation.
￿
For cell surface labeling, 4 x 107 T cells were purified
on Ficoll density gradients, washed with PBS, and labeled using lactoperoxidase in the pres-
ence of 2 mCi sodium 1251, as described (4). After 3 h of lysis in 0.3% 3-[(3-Cholamido-
propyl) dimethyl-ammonio]-1-propanesulfonate (CHAPS)/Tris-buffering saline containing
7.5 mM iodoacetamide (Sigma Chemical Co., St. Louis, MO) and 1 mM PMSF (Sigma
Chemical Co.), the lysates were precleared, as described (4). For ßF1 and antiTCRS1 immu-
noprecipitation, 1% Triton X-100 was added before addition of specific mAb to augment
the dissociation of the TCRCD3 complex. The specific immunoprecipitations were performed
using 100 pl P3 (negative control), A2B4, 2C11 and antiTCRS1 hybridoma supernatants,
0.5 pl ßF1 ascites, or 1 gg anti-Leu-4 (Becton Dickinson & Co.) in the presence of 100 PI
rat anti-mouse K chain-specific mAb 187 .1 to facilitate binding of the immune complexes
to 100 pl l05 Jo (vol/vol) protein A-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ).
The beads were washed in 0 .1 % Triton X-100 containing buffer. Before loading the samples
on a 10% acrylamide gel, half of each immunoprecipate was reduced in DTT as described.
For diagonal gels, samples were run under nonreducing conditions for 12 h in 7.57o SDS-
PAGE tube gels at 0 .25 mA per tube. Tube gels were then incubated in reducing sample buffer
for 2 h at room temperature, layered on top of a 10% SDS-PAGE slab gel, and run 12 h
at 6 mA per gel. Gels were dried, and labeled proteins were visualized by autoradiography.
For metabolic labeling, 2 x 107 exponentially growing cells were resuspended in 4 ml of
methionine and cysteine-free RPMI 1640 (Select-Amine kit; Gibco Laboratories, Grand Is-
land, NY) supplemented with l0olo dialysed FCS and 20 mM Hepes. After a 30-min starva-
tion at 37°C, 0.5 mCi of "S-methionine and 0.5 mCi of "S-cysteine was added, followed
by a 3-h labeling period. Cells were harvested and lysed for 1 h in 1% (wt/vol) digitonin-
(Aldrich Chemical Co., Milwaukee, WI) supplemented Tris-buffered saline (TBS) (50 mM
Tris, pH 7.6, 140 mM NaCI) containing freshly added 1 mM PMSF and 8 mM IAA. The
lysates were precleared by incubating with normal rabbit serum and 187.1 hybridoma culture
supernatant, followed by addition of 200 pd ofa 10% (wt/vol) cell suspension offixed Staphylo-1006
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coccus aureus Cowan I (Pansorbin; Calbiochem-Behring Corp., San Diego, CA). Specific precipi-
tations were carried out by adding 0.25 ul OF1 ascites, 0.5 ul anti-Cyml ascites, 0.2 RI anti-
TCRS1 ascites, 1 jI 1 mg/ml anti-Leu-4 or 0.5 ml NMS together with 200 PI of 187 .1
supernatant to each sample. After a 1-h incubation, 100 ul of 10% (vol/vol) protein A-Sepharose
(Pharmacia Fine Chemicals) was added, and the mixture was rocked for 1 h. The immuno-
precipitates were washed four times in 0.1% Triton X-100, TBS and three times in 1 % digitonin,
TBS. Half of each sample was reduced with DTT, the other half was analyzed under non-
reducing conditions. The samples were resolved on a 10% acrylamide gel, and fluorography
was performed as described (41).
Results
Conversion ofyS' PEER Cells into a0' cells After the Expression ofa Transfected Tia Gene.
PEER, a human yS' leukemia cell line, has been extensively analyzed (6, 42). This
cell has the unusual property of also containing an in-frame R mRNA that gives
rise to R chains that assemble intracellularly with CD3 components, but are not trans-
ported to the cell membrane (43, 44). The receptor gene phenotype of this cell
(y'8'0' a°) made it a candidate for a rare transitional cell differentiating from a yS'
to an W lymphocyte. To determine if this tumor cell might be capable of demon-
strating feedback inactivation ofthe yS loci upon expression of a functional UP-CD3
complex, we introduced an a chain-encoding cDNA clone into PEER cells.
We have previously shown that both mouse a-human R and human a-mouse Q
heterodimers can be expressed in association with the human CD3 complex on the
cell surface after transfection of mouse Ti genes into human T cells (2, 45). There-
fore, the human PEER cell line was transfected with an expressible form of a func-
tional full length cDNA clone of the Tia gene of the murine I-Ek-restricted, cyto-
chrome c-specific T cell hybridoma 2B4 (2, 26). Transfectants were screened by both
surface staining with the A2B4 mAb, which is known to react with the 2B4a chain
in isolation or associated with a variety of partner chains (2), and by RNA dot blot
analysis using a Va2B4 probe. More than 30 2B4a-transfected PEER clones were
obtained in this manner. Six independent clones have been analyzed in detail by
staining and immunoprecipitation, and all six showed almost identical patterns of
TCR expression. We describe here a representative clone, PE-a-1.3 .
Fig. 1 shows the staining profiles of the parental PEER line and of the Tia-
transfected clone PE-a-1.3. PEER shows a broad, somewhat dull pattern of surface
CD3 expression. As expected, staining with A2B4 is absent, as is staining with WT31,
known to react with a common epitope on human ap dimers. In contrast, PE-a-1.3
shows bright staining with anti-CD3 as well as WT31 and A2B4 antibodies. The most
likely explanation for this result is the expression ofhuman R-mouse a heterodimers
on the cell surface, reactive with both the A2B4 and the WT31 antibodies. However,
because Van de Griend et al. (46) have recently found that WT31 reacts with some
yS' T cells, the positive staining of PE-a-1 .3 with WT31 does not conclusively in-
dicate Ti a(3 expression.
To more directly determine the nature of the receptor chains expressed on the
surface of the transfected PEER cells, immunoprecipitation and SDS-PAGE were
performed. Both PEER and PE-a-1.3 cells were surface iodinated, followed by lysis
with 5 mM CHAPS to preserve the Ti/CD3 complex (6). Labeled proteins were
immunoprecipitated from the cell lysates with various mAbs (Fig. 2). No specific
bands were observed after treatment of the PEER cell lysate with either A2B4 org
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FIGURE 1. Cell surface expression of Ti/CD3 by 2134a-
transfected PEER cells. 5 x 105 PEER (A), PE-a-1.3 (B), or
2134 (C) were stained with culture supernatants of A2134.2
(- - - -), OKT3 (-), or a 1 :500 dilution ofascites ofWT31
(. . .), or medium alone ( ), followed by Ruoresceinated
(Fab')2 goat anti-mouse Ig and then analyzed using a FRCS
analyzer. The results represent analysis of 104 cells.
with an mAb reactive with a framework determinant of human 0 chains (ßF1, 32).
As expected, anti-Leu-4 (anti-CD3) precipitated a 55-kd y chain together with a
40-kd S chain in association with CD3 proteins. On PEER cells, the TCR y and
S chains are noncovalently associated. Use of a recently described mAb directed at
human S chains (antiTCRS1, 33) also led to precipitation of the 55-kd y chain and
the CD3 chains, but very little visible S chain. This difficulty in visualizing the PEER
S chain after surface iodination has been noted previously (6, 42).
In contrast to the results with the parental cell line, precipitation of proteins from
the PE-a-1.3 lysate with anti-Leu-4 revealed the presence of an 80-kd species that
was recognized both by A2134 and ßF1 and, therefore, represents a Ti aß hetero-
dimer. This Ti a0 species yielded a broad 39-43-kd band upon reduction. These
data are consistent with the staining results and indicate that 2134a and PEER 0
chains are associated with the CD3 complex on the surface of PE-a-1.3. Surpris-
ingly, anti-Leu-4 precipitation did not show any detectable 55-kd y chain. This ap-
parent loss ofychain expression was confirmed by the failure to detect y chain pro-
tein after immunoprecipitation with the antiTCRSI antibody. Six independent
transfectant clones all showed this same loss of surface yS expression concomitant
with the appearance of surface aß dimers.
These data made several points. First, the absence of a ßF1-reactive species on
the PEER cell surface before transfection implied that the PEER 0 chain cannot
be transported to the cell surface in association with either they or S chain. Neverthe-
less, these findings also indicated that the PEER 0 chain is functional and can be
expressed with an a chain on the cell surface. Second, the unexpected loss ofyS sur-1008
￿
CONTROL OF T CELL RECEPTOR DIMER EXPRESSION
FIGURE 2 .
￿
Immunoprecipitation of proteins from lysates of surface-labeled PEER and PE-a-
1 .3 cells. PEER and PE-a-1 .3 cells were surface iodinated, lysed, and the lysates were used for
immunoprecipitation with the indicated mAbs. Immunoprecipitated samples were analyzed by
SDS-PAGE using 10 0 1o gels undernonreducing (N) and reducing (R) conditions . Molecular size
markers are indicated as kD in the margin .
face expression at the time of acquisition of the ao phenotype suggested a possible
feedback regulation of receptor expression in this cell line.
Introduction of a Functional a Gene into PEER Does not Lead to a Change in yS mRNA
Expression. To determine if the loss of surface yS dimer expression after a gene trans-
fection into PEER was due to negative regulation of yS mRNA levels, the steady-
state amounts of TimRNAs in the parent and transfectant cell lines were examined .
Fig. 3 shows the results of Northern blot analysis usingcDNA probes corresponding
to the constant regions of human Tia, R, and S genes and to the V region of the
mouse 2B4a gene . Ca and C(3 blots show that both PEER and PE-a-1.3 express no
human a mRNA, but they do have approximately equal and high levels of full-length
1.3-kb (3 mRNA . Cy and CS blots revealed only slightly reduced levels of mature
1.6-kb y chain and 2.2- and 1.3-kb mature S mRNA in the transfected cells . 1.7-
and 0.8-kb S mRNAs, which do not contain V region sequences (15), were also de-
tected in both cells . Fig . 3 also shows the abundant expression of 2134a mRNA in
PE-a-1 .3 . These findings suggest that the switch in Ti phenotype after a gene trans-
fection is not the result of a direct feedback effect of successful aR dimer formation
on the transcription of yS genes or the rate of degradation of the respective mRNAs .SAITO ET AL .
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FIGURE 3 .
￿
Northern blot analysis ofTia-
transfected PEER cells. 10 kg of cyto-
plasmic RNA from E6 .1, PEER, and PE-
a-1.3 were separated on a 1% agarose-
formaldehyde gel, transferred to nitrocel-
lulose, and the blots hybridized to human
a (A), human ß (B), human y (C), human
S (D), or Va2B4 (E) probes . Molecular
sizes in kb are indicated in the margin .
The Failure to Detect yS Expression on PE-a-1.3 May Be Due to Competitionfor CD3 by
aß Dimers. We next labeled PEER and PE-a-1 .3 cells biosynthetically in order to
test whether y and 8 protein can be detected intracellularly. Fig . 4 shows the immu-
noprecipitation results using lysates prepared from cells labeled for 3 h . ßF1 precipi-
tation of protein from the PEER lysate revealed that a large amount of ß protein
is synthesized in PEER cells . Only a fraction of the ß chains is precipitated with
anti-Leu-4, indicating that both free ¢ chains and CD3-associated ß chains exist in-
tracellularly, as reported previously by Koning et al . (43) . The 45- and 48-kD bands
that are associated with CD3 correspond to the TCR y chain precursors, because
they were recognized by anti-Cyml, a monoclonal anti-y chain antibody (53) . Im-
munoprecipitation by antiTCR81 antibody showed a typical single S chain band
that migrated more rapidly under nonreducing conditions . Undernonreducing con-
ditions, 8 could be unequivocally identified afteranti-CD3 precipitation despite the
presence of the more heavily labeled ß species .
The pattern of Ti chains precipitated from lysates of labeled PE-a-1.3 was strik-
ingly different from that obtained with PEER . ßF1 precipitation again showed abun-
dant intracytoplasmic ß chain . However, the anti-Leu-4 antibody coprecipitated only
ß, but no detectable y chains along with CD3. Precipitation with anti-Cyml anti-
body did reveal a small amount ofy chain precursor in the PE-a-1.3 lysates, but101 0
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FIGURE 4 .
￿
Immunoprecipitation of proteins from lysates of metabolically-labeled PEER and
PE-a-1 .3 cells . PEER and PE-a-1 .3 cells were metabolically labeled for 5 h with 3 .,S-methionine
and 3'S-cysteine, lysed, and the lysates used for immunoprecipitation with indicated mAbs . Im-
munoprecipitated samples were analyzed by SDS-PAGE using 10% gels under nonreducing (~
and reducing (R) conditions . Molecular size markers in kD are indicated in the margin .
these chains were not detectably associated with CD3 components . Furthermore,
we could only observe S chain after prolonged exposure of the gels (data not shown) .
Thus, after the introduction ofa functional a chain-encoding gene into PEER, TCR
S chain polypeptides are virtually undetectable, and y chain precursors are present
in only minor amounts . Because S and y mRNA are only modestly reduced under
these conditions, these findings are most consistent with a post-translational decrease
in intracellular y and S levels . This may be the result ofabundant aR dimers in the
transfectant outcompeting yS for limitingCD3 components, leading to degradative
loss of unassembled S and y chains .
Transfection to Ti a and# Genes into aMurine y6+ Hybridoma.
￿
Because of the asym-
metry in chain synthesis in the transfected PEER cell, leading apparently to the
competitive loss of yS assembly with CD3, we could not use this model to extend
our analysis of the possible pairings of Ti chains of various types . In an attempt
to overcome this experimental limitation, and also to determine if there is a special
bias in ao vs. yS association with CD3 proteins, we have examined a second inde-
pendent system involving the introduction of Ti a and/or R genes into a murine y8+
hybridoma .SAITO ET AL .
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FIGURE 5 .
￿
Northern blot analysis of2B4a- and/or p-trans-
fectedDN7 .1 hybridomas . 10 ug ofcytoplasmicRNA from
2B4, DN7 .1, DNl-p-1 .23, DN1-a-1 .15, and DNl-p.a-1 .3 were
separated on a 1°Jo agarose-formaldehyde gel, transferred
to nitrocellulose, and the blots hybridized to Va2B4 (A),
Vp2B4 (B), or Cy (C) probes . Molecular sizes in kb are in-
dicated in the margin .
The DN7.1 y8+ murine hybridoma, previously described in detail (27), was chosen
for these experiments . Briefly, DN7 .1 was produced by fusion ofC57BL/6 dull Ly1 +
CD4-CD8- thymocytes with a BW5147 lymphoma variant that has lost the expres-
sion of its functional Ti R gene. DN7.1 therefore expresses BW5147a chainmRNA
but not mature RchainmRNA . On the cell surface, DN7 .1 expresses disulfide-linked
47-kb S and 34-kD y chains but no ao dimers . Fig. 5 shows the results of Northern
blot analysis ofrepresentative clones of2B4 a and/or 2B40 gene-transfected DN7.1 .
The parent DN7 .1 does not express any mRNA hybridizing with V region probes
for the 2Ba or Q genes . The 2B4a single-gene tranfectant (DN1-R-1.23) has the ex-
pected 2B4R gene transcript and, similarly, the 2B4a single-transfectant (DN1-a-
1 .15) expresses specific 2B4a mRNA . The two Vall-containing transcripts of 2.1
and 3.4 kb are larger than the authentic 2B4a transcript and are due to the nature
of thecDNA expression vector used to express this cDNA . Finally, a 2B4a and 2B4(3
gene-transfected DN7.1 (DNl-(3 .a-1.3) expresses both specific a and 0 chain tran-
scripts .CONTROL OF T CELL RECEPTOR DIMER EXPRESSION
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FIGURE 6 .
￿
Cell surface expression of 2B4a
chain by 2B4a- and/or a-transfected DN7 .1
cells . 5 x 10 5 DN7.1 (A), 2B4 (E), or Ti-
transfected DN7.1 cells (B-D) were stained
with culture supernatant of 2C11 (- - - -),
A2B4 .2 (--),or medium alone (
￿
), fol-
lowed by fluoresceinated (Fab')2 goat
anti-mouse Ig, and then analyzed by aFRCS
analyzer. The results represent analysis of 104
cells .
Fig . 6 depicts immunofluorescence profiles of the DN7.1 cell and of2B4 a and/or
R gene transfectants stained with A2B4 and/or the anti-mouse CD3e antibody 2C11 .
All cells showed expression of the CD3c epitope, consistent with the continued ex-
pression ofsome type ofTi-CD3 complexes on the cell surface. The parentalDN7 .1
cells, the R gene single transfectant, and the 2B4a gene single transfectant did not
express 2B4a chain on the surface . This result indicates that 2B4a chain does not
pair with either the 7 or S chain to yield heterodimers able to associate with CD3
FIGURE 7 .
￿
Immunoprecipitation ofproteins
from lysates of surface-labeled 2B4as-trans-
fected DN7.1 cells . 2B4, DN7.1, or DNl-
p.a-1.3 were surface iodinated, lysated, and
the lysates used for immunoprecipitation with
2C11, A2B4 .2, or normal mouseserum as con-
trol . Immunoprecipitated samples were ana-
lyzed by SDS-PAGE using 10% gels under
reducing conditions . Molecular size markers
in kD are indicated in the margin . The band
of -60 kd in the control lane ofDN7.1 was
not observed on repeat gels .SAITO ET AL .
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FIGURE 8 .
￿
Two-dimensional gel analysis of Ti/CD3 complexes on Tia(i-transfected DNT1 cells .
2134, DN7.1, and DNl-p .a-1 .3 cells were surface iodinated, lysed, andthe lysates used forimmu-
noprecipitation . Immunoprecipitated samples were analyzed in diagonal gels (7.5% nonreducing
(NR) gel for the first dimensionand 10% reducing (R) gel for the second dimension). (A) Proteins
from each lysate of 2134, DN7.1, or DNl-D.a-1 .3 were precipitated with 2C11 . (B) Proteins from
the lysate of DNl-p.a-1 .3 were precipitated with 201, A2134, or anti-y heteroantibodies, respec-
tively . Molecular size markers in kD are indicated in the margin .
and be transported effectively to the membrane . The control 2B4a and p gene double
transfectants express 2B4a chain on the surface as expected (Fig . 6 D), although
the level of the expression is only 20% that of 2B4 .
Absence of Unusual Receptor Dimers on Cells Expressing all Four Ti Chains .
￿
To analyze
all the Ti/CD3 complexes on Tiap-transfected y8+ hybridomas, 2B4 (ap + ), DN7 .1
(y8+ ), DN1-p-1.23 (Tip transfectant), and DNl-0 .a-1 .3 (Tiap transfectant) cells were
surface iodinated, cell lysates prepared, and the labeled proteins immunoprecipi-
tated with either 2C11 or A2B4 (Fig . 7) . Both 2C11 andA2B4 precipitated ap dimers
from the control 2B41ysate . The uncommonly high molecular weight receptor band
in this precipitate has been recently shown to be BW5147p chain (T. Saito and R.
Germain, unpublished observation). Precipitation ofDN7.1 with 2C11 showed the
two expected bands, corresponding to the 47-kd S chain and the 34-kd y chain . No
proteins were specifically immunoprecipitated from theDN7 .1 lysate by A2134. In
contrast, when 2B4ap-transfectant DN1-p.a-1.3 proteins were precipitated with 2C11,
a new broad band was observed between the y and S chain bands at -39-43 kd,
indicating the presence of ap dimers (2B4a-2B40 and BW5147a-2B40) expressed
in association with CD3. Confirming this, A2B4 precipitation results in visualiza-101 4
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tion of an a0 band migrating in between the positions of the y and S chains. No
associated y or S chains are seen in A2B4 precipitates from these transfectant ly-
sates. These results suggest that a0 dimers exist independently from yS dimers on
the same cell membrane. Similar findings about simultaneous expression of all four
Ti chains on the surface of a single cell were obtained using the 0 gene single-trans-
fectant DN1-0-1.23 (data not shown). However, the lack ofthe 2B4 a chain precluded
direct demonstration of the preferential expression of a0 and yS dimers seen with
the double (a0) transfectant.
To provide a more detailed picture of the various combinations of Ti chains ex-
pressed on the cell membrane of these transfectants, the unreduced-reduced "diagonal"
gel technique was used. In Fig. 8 A, surface-labeled cell lysates from 2B4 (a0+ ),
DN7.1 (y8+ ), and DNl-0.a-1.3 (aD+ yS+ ) were immunoprecipitated with a single an-
tibody, 2C11. Consistant with the results from one-dimensional gels, DN7 .1 yielded
two offdiagonal spots representing the y and S chains, whereas, the a0+ transfec-
tant also showed a typical a0 dimer in between these y and 8 chain spots that
comigrated with the control a0 precipitate from 2B4. In Fig. 8 B, the surface pro-
teins of DNl-0 .a-1.3 were precipitated using three different antibodies; 2C11 (anti-
C133), A2B4 (anti-2B4a), and an anti-y heteroantiserum. 2C11 again precipitated
all four Ti chains together with CD3. In contrast, precipitation with A2B4 brought
down only a0 chains, without any coprecipitatingy or S . Finally, precipitation with
an anti-y antiserum revealed only y and S chains, without any a or 0. These results
indicate that when all four Ti chains were expressed on the cell surface of single
clone, Ti molecules showed preferential chain association, that is, only a0 and/or
yS, but no ay, aS, 0y, or 0S combinations were observed.
Discussion
We have investigated the effects of simultaneously expressing functional chains
of both TCR types (a0 and yS) in a single T cell. In one model system involving
the human cell PEER, creation of an expressible a0 dimer after gene transfer led
to the extinction of surface yS expression and good a0 expression . This phenotypic
conversion did not appear to be the result of gene regulation, but rather intracellular
competition for CD3 components necessary for membrane receptor expression. This
was consistent with data from a murine model, in which simultaneous surface ex-
pression of both yS and a0 dimers was observed. In neither case were mixed dimers
found on the cell surface, indicating a stringent chain specificity to heterodimer for-
mation and/or transport.
Based on initial ontogenic studies demonstrating the sequential expression of Tiy,
0, and then a genes, it was proposed that some immature thymocytes might express
y0 receptors with self-MHC reactivity (16, 17). More recent results have indicated
that surface y- and 0-expressing thymocytes are distinct, with no evidence for dual-
expressing cells (21). However, the existence of a transitional population could not
be ruled out by these studies. Our results provide direct evidence against the notion
of such a transitional y0-expressing population, as even when all four subunits (a,
0, y, and S) are present in a single cell, surface membrane Ti molecules consist solely
of a0 and yS heterodimers.
In this context, PEER is a very unusual cell that, unlike other y8+ T cells, pos-SAITO ET AL.
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sesses a functional p protein. This is the phenotype one might expect for a cell
differentiating from y8+ to aP`, a process that might occur even though a direct
relationship between the receptors in the two differentiation states (via yo dimers)
is ruled out. Indeed, y8 + PEER cells showedjust such a change in surface receptor
expression after transfection of an intact Tia gene.
Examination of the mechanism by which this switch occurred made it unlikely
to represent a normal physiologic mechanism. Thus, the failure to detect CD3-
associated y and 8 chains in Tia-transfected PEER was not to transcriptional down-
regulation of y or 8 genes after the expression of complete a(3 dimers, as the Tia-
transfectant possessed apparently full-lengthy and 8 mRNA in amounts similar to
the parental PEER line. Rather, it appears that the Tia-transfectant produces so
much a(3 dimer in comparison with y8 dimer that the former successfully competes
for a limiting amount of CD3 components necessary for surface Ti expression. The
apparently disproportional decreases in y and 8 protein levels as compared with
mRNA levels may thus be due to degradation, because others have already shown
that Ti chains not fully assembled into transportable Ti-CD3 complexes are rapidly
destroyed (47).
In contrast to the results obtained with PEER, the presence of complete a(3 dimers
did not prevent simultaneous y8 expression in the case of Ti a(3-transfected mouse
y8 hybridomas . In fact, the surface level of a(3 dimer is much lower than y8 dimer
in this case, supporting the conclusion above that the extinction of yS expression
in Ti a-transfected PEER is the result of a low level of yS and a much higher level
of aR dimer. The ability of low levels of a(3 dimers in DM-(3.a-1.3 to successfully
compete for CD3 components with a larger amount of y8 dimers might reflect a
higher affinity of aR dimers for T3 components, a notion consistent with the change
in the biochemical properties of CD3 noted in y8- vs. a(3-expressing human (though
not mouse) T cells (48) . Whether theseeffects of heterodimer isotype on CD3 relate
to differences in efficiency of assembly or rate oftransport remains to be determined,
however.
Our biochemical analysis of both a-transfected PEER and Tia(3-transfected mouse
y8 hybridoma cells indicates that Tia(3-CD3 and Tiy8-CD3 complexes are expressed
independently on the cell surface and that receptors containing mixed dimers such
as ay, aS, ay, or 08 are not transported to the cell membrane under these condi-
tions . For example, Ry and 08 dimers were not observed using anti-R chain ((3F1)
and anti-8 chain (antiTCR81) antibodies and labeled PEER or transfected PEER
cells, and ay, a8, or Ry dimers were not observed using anti-a chain (A2134) and
anti-y chain antibodies in studies with a(3-transfected mouse y8 cells. It is unlikely
that our failure to observe mixed dimers is the result of the particular genes used
for these experiments, as we have analyzed two independent systems and several
possible combinations of chains. Limited analysis of biosynthetically labeled mate-
rial additionally suggests that such mixed dimers are also not present in significant
amounts within the cell, implying that either these dimers do not form at all, or,
perhaps due to problems with full assembly with CD3 components, are rapidly
degraded.
One caveat to this conclusion that receptor chain mixing does not occur comes
from studies we have carried out on the assembly and transport of class II MHC-101 6
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encoded molecules (Ia molecules). Using an L cell transfection model, interisotypic
pairing of AP with Ea, followed by transport of the assembled dimer to the mem-
brane, has been observed (49, 50). Despite this, such dimers cannot be demonstrated
in or on normal la-expressing cells of the appropriate H-2 haplotype (51). Recent
results with transfectants containing Ea together with both AP and ER indicate that
there is a definite isotype preference in assembly/transport of class II molecules (A.
Sant and R. Germain, manuscript in preparation). Thus, the absence of the mixed
la molecules in normal cells is probably due to consumption of available chains by
preferential pairing with isotypically matched partners, even though the isotype-
mixed dimer can be formed and transported when the proper chains are present
in a cell by themselves. Similar effects may preclude our detection of mixed receptor
dimers that might be seen if the component chains were present without the usual
partner in the cell. We are currently transfecting a Ti- target cell with the appro-
priate gene combinations to address this question directly.
Based on sequence homology to Igs, all four TCR chain types have been predicted
to have a similar structure consisting of two Ig-like domains. Given this presumed
close correspondence in structure, it is somewhat surprising that there is such a strict
segregation of partner chains in the expression of TCRs by a single cell expressing
functional products ofall four receptor loci. What part ofeach receptor chain mediates
the preferential formation or transport of a(3 and yS complexes has yet to be deter-
mined. Although preservation of pairing among the V region-diversified popula-
tions of receptor chains with the same C region suggests a C region rather than
a V region-controlled event, we have previously found that the allelically polymorphic
(nonconserved) portions of class II MHC molecules play critical roles in determining
the efficiency of dimer formation and transport (50, 52). Furthermore, preliminary
results indicate that the level of expression of certain pairs of a and R chains seems
to depend predominantly on the V region sequences, indicating that these variable
segments can have a significant role in either the assembly or transport efficiency
of TCR (T. Saito and R. Germain, manuscript in preparation) . Because a separate
set of V regions is used by each receptor chain (with perhaps rare exceptions for
certain a and S chains), the pattern we have observed could be in large measure
controlled by these regions. Analysis of the expression patterns of recombinant chains
in transfected cells will provide a means for exploring these issues.
Overall, the results presented here suggest that the chains ofthe two known types
of Ti dimers, aQ and yS, have evolved to generate two distinct sets of receptor struc-
tures. Their expression appears to be mutually exclusive and mixing of chains usu-
ally found in the prototypic receptor dimers is inefficient or nonexistent. Because
the effector functions (cytolytic activity, lymphokine production) of T cells bearing
either of the two receptor types are similar if not identical, these results suggest that
these two receptor types most likely function to provide their respective cells with
diverse and probably minimally overlapping sets of specificities, enabling a larger
antigenic universe to elicit immune effector activity than if only one or the other
dimer-mediated recognition for all T cells.
Summary
Surface expression of TCR dimers by cells synthesizing threeor four distinct types
of receptor chains was analyzed . Cells containing intact y, a, and 0 chains had onlyyS dimers on the cell surface. In human PEER cells, addition of a functional a chain
led to the loss of yS dimer expression and expression of only aR dimers. This result
was not due to transcriptional down-regulation of the y or S loci. In murine cells
expressing all four chains, both yS and a(3 dimers could be demonstrated on a single
cell . No other chain combinations (ay, aS, Qy, or (3S) were detected. Thus, there
is stringent control of assembly and/or transport of TCR heterodimers, such that
functional receptors consist only of a(3 and yS pairs, and no additional repertoire
diversity is generated by cross pairing.
Receivedfor publication 26 May 1988.
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